Fangzhou Inc. has announced the launch of Kyinsu®, the world's first once-weekly basal insulin/GLP-1 RA combination ...
Galderma has announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC reg...
Merck, a leading science and technology company, has opened a new €25 million BioReliance® testing facility at ...
Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distri...
AstraZeneca has entered into an exclusive license agreement with China-based Dizal Pharmaceutical for Zegfrovy ...
India's Sai Parenterals has announced that its Australian subsidiary, Noumed Pharmaceuticals, has successfully renewed i...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treat...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
US-based GEM Global Yield LLC SCS has executed a Share Purchase Agreement (SPA) with the existing shareholders of Taiwan...
Japanese pharma firm Takeda and the Indonesian Government (the Ministry of Health, the Ministry of Investment and D...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, alongside Astra...
India's Godavari Biorefineries has been granted a patent by the Japan Patent Office for its breakthrough invention, "5-H...
Bristol Myers Squibb (BMS), a global biopharmaceutical leader, recently celebrated its 60th anniversary in Singapore by ...
Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has announced that its wholly owned subsi...
Japan-based Tanabe Pharma has decided to transfer the domestic manufacturing and marketing approvals, manufacturing and ...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
University College London (UCL) and Japanese pharma firm Eisai have signed a new agreement to extend their long-standing...
Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and...
China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the offi...
The Faculty of Pharmacy, Mahidol University (MUPY), Thailand, has signed a Memorandum of Understanding (MoU) with We-Win...
Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings, Singapo...
Arcera Life Sciences, a global life sciences company focused on advancing innovative and sustainable healthcare solution...
Eli Lilly Drugstore LLC (Lilly) and the Department of Health – Abu Dhabi (DoH), regulator of the healthcare sector...
Since the expansion, the Peenya facility has evolved into a key hub for Merck KGaA—what would you consider its mos...
